These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

575 related articles for article (PubMed ID: 34565108)

  • 1. Early combination therapy with hydroxychloroquine and azithromycin reduces mortality in 10,429 COVID-19 outpatients.
    Million M; Lagier JC; Tissot-Dupont H; Ravaux I; Dhiver C; Tomei C; Cassir N; Delorme L; Cortaredona S; Amrane S; Aubry C; Bendamardji K; Berenger C; Doudier B; Edouard S; Hocquart M; Mailhe M; Porcheto C; Seng P; Triquet C; Gentile S; Jouve E; Giraud-Gatineau A; Chaudet H; Camoin-Jau L; Colson P; Gautret P; Fournier PE; Maille B; Deharo JC; Habert P; Gaubert JY; Jacquier A; Honore S; Guillon-Lorvellec K; Obadia Y; Parola P; Brouqui P; Raoult D
    Rev Cardiovasc Med; 2021 Sep; 22(3):1063-1072. PubMed ID: 34565108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, France.
    Million M; Lagier JC; Gautret P; Colson P; Fournier PE; Amrane S; Hocquart M; Mailhe M; Esteves-Vieira V; Doudier B; Aubry C; Correard F; Giraud-Gatineau A; Roussel Y; Berenger C; Cassir N; Seng P; Zandotti C; Dhiver C; Ravaux I; Tomei C; Eldin C; Tissot-Dupont H; Honoré S; Stein A; Jacquier A; Deharo JC; Chabrière E; Levasseur A; Fenollar F; Rolain JM; Obadia Y; Brouqui P; Drancourt M; La Scola B; Parola P; Raoult D
    Travel Med Infect Dis; 2020; 35():101738. PubMed ID: 32387409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes of 3,737 COVID-19 patients treated with hydroxychloroquine/azithromycin and other regimens in Marseille, France: A retrospective analysis.
    Lagier JC; Million M; Gautret P; Colson P; Cortaredona S; Giraud-Gatineau A; Honoré S; Gaubert JY; Fournier PE; Tissot-Dupont H; Chabrière E; Stein A; Deharo JC; Fenollar F; Rolain JM; Obadia Y; Jacquier A; La Scola B; Brouqui P; Drancourt M; Parola P; Raoult D;
    Travel Med Infect Dis; 2020; 36():101791. PubMed ID: 32593867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hydroxychloroquine in the treatment of adult patients with Covid-19 infection in a primary care setting (LIBERTY): A structured summary of a study protocol for a randomised controlled trial.
    Vainio PJ; Hietasalo P; Koivisto AL; Kääriäinen S; Turunen J; Virtala M; Vuorinen J; Scheinin M
    Trials; 2021 Jan; 22(1):44. PubMed ID: 33430933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical outcomes and adverse events in patients hospitalised with COVID-19, treated with off-label hydroxychloroquine and azithromycin.
    Kelly M; O'Connor R; Townsend L; Coghlan M; Relihan E; Moriarty M; Carr B; Melanophy G; Doyle C; Bannan C; O'Riordan R; Merry C; Clarke S; Bergin C
    Br J Clin Pharmacol; 2021 Mar; 87(3):1150-1154. PubMed ID: 32687645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early Outpatient Treatment of Symptomatic, High-Risk COVID-19 Patients That Should Be Ramped Up Immediately as Key to the Pandemic Crisis.
    Risch HA
    Am J Epidemiol; 2020 Nov; 189(11):1218-1226. PubMed ID: 32458969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hydroxychloroquine plus azithromycin early treatment of mild COVID-19 in an outpatient setting: a randomized, double-blinded, placebo-controlled clinical trial evaluating viral clearance.
    Rodrigues C; Freitas-Santos RS; Levi JE; Senerchia AA; Lopes ATA; Santos SR; Siciliano RF; Pierrotti LC
    Int J Antimicrob Agents; 2021 Nov; 58(5):106428. PubMed ID: 34454044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute QT Interval Modifications During Hydroxychloroquine-Azithromycin Treatment in the Context of COVID-19 Infection.
    Voisin O; Lorc'h EL; Mahé A; Azria P; Borie MF; Hubert S; Ménage E; Guillerm JC; Mourad JJ
    Mayo Clin Proc; 2020 Aug; 95(8):1696-1700. PubMed ID: 32753141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacoepidemiology, Machine Learning, and COVID-19: An Intent-to-Treat Analysis of Hydroxychloroquine, With or Without Azithromycin, and COVID-19 Outcomes Among Hospitalized US Veterans.
    Gerlovin H; Posner DC; Ho YL; Rentsch CT; Tate JP; King JT; Kurgansky KE; Danciu I; Costa L; Linares FA; Goethert ID; Jacobson DA; Freiberg MS; Begoli E; Muralidhar S; Ramoni RB; Tourassi G; Gaziano JM; Justice AC; Gagnon DR; Cho K
    Am J Epidemiol; 2021 Nov; 190(11):2405-2419. PubMed ID: 34165150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcome of noncritical COVID-19 patients with early hospitalization and early antiviral treatment outside the ICU.
    Çalık Başaran N; Uyaroğlu OA; Telli Dizman G; Özışık L; Şahin TK; Taş Z; İnkaya AÇ; Karahan S; Alp Ş; Alp A; Metan G; Zarakol P; Sain Güven G; Öz ŞG; Topeli A; Uzun Ö; Akova M; Ünal S
    Turk J Med Sci; 2021 Apr; 51(2):411-420. PubMed ID: 32718127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of azithromycin and hydroxychloroquine in patients hospitalized with COVID-19: Network meta-analysis of randomized controlled trials.
    Chi G; Memar Montazerin S; Lee JJ; Kazmi SHA; Shojaei F; Fitzgerald C; Gibson CM
    J Med Virol; 2021 Dec; 93(12):6737-6749. PubMed ID: 34370328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of chloroquine or hydroxychloroquine in COVID-19 patients: a systematic review and meta-analysis.
    Kashour Z; Riaz M; Garbati MA; AlDosary O; Tlayjeh H; Gerberi D; Murad MH; Sohail MR; Kashour T; Tleyjeh IM
    J Antimicrob Chemother; 2021 Jan; 76(1):30-42. PubMed ID: 33031488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of Recovery Time, Worsening, and Death among Inpatients and Outpatients with COVID-19, Treated with Hydroxychloroquine or Chloroquine plus Azithromycin Combination in Burkina Faso.
    Rouamba T; Ouédraogo E; Barry H; Yaméogo NV; Sondo A; Boly R; Zoungrana J; Ouédraogo AR; Tahita MC; Poda A; Diendéré AE; Ouedraogo AS; Valea I; Traoré I; Tarnagda Z; Drabo MK; Tinto H;
    Int J Infect Dis; 2022 May; 118():224-229. PubMed ID: 35227869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Outcome of Hydroxychloroquine in Patients Treated for COVID-19: Systematic Review and Meta-Analysis.
    Ayele Mega T; Feyissa TM; Dessalegn Bosho D; Kumela Goro K; Zeleke Negera G
    Can Respir J; 2020; 2020():4312519. PubMed ID: 33082891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COVID-19 outpatients: early risk-stratified treatment with zinc plus low-dose hydroxychloroquine and azithromycin: a retrospective case series study.
    Derwand R; Scholz M; Zelenko V
    Int J Antimicrob Agents; 2020 Dec; 56(6):106214. PubMed ID: 33122096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hydroxychloroquine with or without azithromycin for treatment of early SARS-CoV-2 infection among high-risk outpatient adults: A randomized clinical trial.
    Johnston C; Brown ER; Stewart J; Karita HCS; Kissinger PJ; Dwyer J; Hosek S; Oyedele T; Paasche-Orlow MK; Paolino K; Heller KB; Leingang H; Haugen HS; Dong TQ; Bershteyn A; Sridhar AR; Poole J; Noseworthy PA; Ackerman MJ; Morrison S; Greninger AL; Huang ML; Jerome KR; Wener MH; Wald A; Schiffer JT; Celum C; Chu HY; Barnabas RV; Baeten JM;
    EClinicalMedicine; 2021 Mar; 33():100773. PubMed ID: 33681731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hydroxychloroquine in Hospitalized Patients with COVID-19: Real-World Experience Assessing Mortality.
    Annie FH; Sirbu C; Frazier KR; Broce M; Lucas BD
    Pharmacotherapy; 2020 Nov; 40(11):1072-1081. PubMed ID: 33044019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early hydroxychloroquine but not chloroquine use reduces ICU admission in COVID-19 patients.
    Lammers AJJ; Brohet RM; Theunissen REP; Koster C; Rood R; Verhagen DWM; Brinkman K; Hassing RJ; Dofferhoff A; El Moussaoui R; Hermanides G; Ellerbroek J; Bokhizzou N; Visser H; van den Berge M; Bax H; Postma DF; Groeneveld PHP
    Int J Infect Dis; 2020 Dec; 101():283-289. PubMed ID: 33007454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hydroxychloroquine/Azithromycin Therapy and QT Prolongation in Hospitalized Patients With COVID-19.
    O'Connell TF; Bradley CJ; Abbas AE; Williamson BD; Rusia A; Tawney AM; Gaines R; Schott J; Dmitrienko A; Haines DE
    JACC Clin Electrophysiol; 2021 Jan; 7(1):16-25. PubMed ID: 33478708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment with hydroxychloroquine, azithromycin, and combination in patients hospitalized with COVID-19.
    Arshad S; Kilgore P; Chaudhry ZS; Jacobsen G; Wang DD; Huitsing K; Brar I; Alangaden GJ; Ramesh MS; McKinnon JE; O'Neill W; Zervos M;
    Int J Infect Dis; 2020 Aug; 97():396-403. PubMed ID: 32623082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.